Federal Register notice: FDA makes available a final guidance on Breast Implants Certain Labeling Recommendations to Improve Patient Communication.
Federal Register notice: FDA seeks comments on an information collection extension for Generic Clearance for the Collection of Qualitative Data on Tob...
Federal Register notice: FDA announces the renewal of its Cardiovascular and Renal Drugs Advisory Committee for an additional two years.
FDA warns Indias Panacea Biotec about CGMP violations in its production of finished drugs.
FDA warns Intrathecal Compounding about deficiencies in its production of sterile drugs.
FDA issues a guidance on the content and format for some labeling information for breast implants.
Federal Register notice: FDA announces the availability of a final guidance on Blood Glucose Monitoring Test Systems.
Federal Register notice: FDA makes available a final guidance on assessing Covid19-related symptoms in clinical trials.